Hypertensionor high blood pressure is one of the most common diseases worldwide affecting people and is a major risk factor for stroke, myocardial infarction, vascular disease, and chronic kidney disease. Health care professionals must not only identify and treat patients with hypertension but also should have a good understanding of the side effects that accompany antihypertensive therapy. The aim of this review is to represent the most common adverse drug reactions (ADRs) of the most prescribed antihypertensive drugs.
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R et al. Prevalence, Awareness, Treatment and Control of Hypertension in Rural and Urban Communities in High-, Middle- and Low-Income Countries. JAMA. 2013 Sep 4;310(9):959-68.
Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J. 2013 Jul;34(28):2159-219.
2007 Guidelines for the management of arterial hypertension. Journal of Hypertension, 2007; 25: 1105-1187.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb Cet al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20.
Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, et al. Clinical practice guidelines for the management of hypertension in the community. A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014 Jan;16(1):14-26.
Roush GC, Holford TR, Guddati AK: Chlorthalidone compared with hydrochlorothiazide
in reducing cardiovascular events: Systematic review and network meta-analyses.Hypertension 59:1110, 2012.
Law M., Morris J., Wald N. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann Intern Med. 2008;148:16-29.
Burke TA et al. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006;24:1193-1200.
Burnier M. Renal protection with calcium antagonists: the role of lercanidipine. Curr Med Res Opin. 2013 Dec;29(12):1727-35.
Robles N., Romero B., Garcia de Vinuesa E. et al. Treatment of proteinuria with lercanidipine associated with renin-angiotensin axis-blocking drugs. Renal Failure. 2010;32 (2):192-197.
Mainguy V, Girar D, Maltais F. Effect of bisoprolol on respiratory function and exercite capacity in chronic obstructive pulmonary disease. Am J Cardiol. 2012;10(2):258-263.
Furukawa H, Mawatari K, Koyama K, Yasui S, Morizumi R, Shimohata T, Harada N, Takahashi A, Nakaya Y.Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes. EurJPharmacol. 2011 Jun 25;660 (2-3):485-91.
Stefan MS, Rothberg MB, Priya A, Pekow PS, Au DH, Lindenauer PK. Association between beta-blocker therapy and outcomes in patients hospitalized with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. Thorax. 2012 Nov;67(11):977-84.
Peters R, Beckett N, McCormack T, Fagard R, Fletcher A, Bulpitt C. Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial. Eur Heart J. 2014 Jul;35(26):1712-8.
Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, Stricker B, Mendis S, Hofman A, Mant J, Franco OH. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013 Oct;34(38):2940-8.
Gupta AK, Arshad S, Poulter NR.Compliance safety and effectiveness of fixed dose combinations of antihypertensive agents: a meta analysis. Hypertension. 2010 Feb;55(2):399-407.
Wong J, Patel RA, Kowey PR. The clinical use of angiotensin-converting enzyme inhibitors. ProgCardiovasc Dis. 2004;47:116-30.
Messerli FH. Calcium antagonists in hypertension: from hemodynamics to outcomes, Amer. J. Hypertension. 2002;15;94S-97S.
Email this article (Login required) 
